跳至主要内容
临床试验/JPRN-UMIN000042801
JPRN-UMIN000042801已完成未知

Epidemiological Study to Evaluate the Prevalence and Progression of Diabetic Macular Ischemia in Patients with Diabetic Retinopathy Treated with Panretinal Photocoagulation - EYE DMI

Boehringer Ingelheim International GmbH0 个研究点目标入组 539 人开始时间: 2021年1月12日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
539

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria (Part A and B): Patients currently participating in an interventional trial with an ophthalmologic experimental therapy Exclusion criteria (Part B only): Severe DRIL, i.e., affecting 50% or more of the central one-mm-wide zone centered on the fovea (foveal DRIL), as defined by Sun et al. [R19-4048]* Any concurrent macular abnormality other than DMI and DME that, in the opinion of the investigator, would interfere with the assessment of DMI and DME (e.g., significant macular epiretinal membrane, neovascular age-related macular degeneration, and macular hemorrhage)*

研究者

相似试验